BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Giannetta E, Guarnotta V, Rota F, de Cicco F, Grillo F, Colao A, Faggiano A; NIKE. A rare rarity: Neuroendocrine tumor of the esophagus. Crit Rev Oncol Hematol 2019;137:92-107. [PMID: 31014519 DOI: 10.1016/j.critrevonc.2019.02.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Uccella S, La Rosa S. Looking into digestive mixed neuroendocrine - nonneuroendocrine neoplasms: subtypes, prognosis, and predictive factors. Histopathology 2020;77:700-17. [PMID: 32538468 DOI: 10.1111/his.14178] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
2 Lam AK. Updates on World Health Organization classification and staging of esophageal tumors: implications for future clinical practice. Hum Pathol 2021;108:100-12. [PMID: 33157124 DOI: 10.1016/j.humpath.2020.10.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mastracci L, Rindi G, Grillo F, Solcia E, Campora M, Fassan M, Parente P, Vanoli A, La Rosa S. Neuroendocrine neoplasms of the esophagus and stomach. Pathologica 2021;113:5-11. [PMID: 33686305 DOI: 10.32074/1591-951X-229] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Vitale G, Carra S, Ferraù F, Guadagno E, Faggiano A, Colao A; NIKE. Gastroenteropancreatic neuroendocrine neoplasms and inflammation: A complex cross-talk with relevant clinical implications. Crit Rev Oncol Hematol 2020;146:102840. [PMID: 31918344 DOI: 10.1016/j.critrevonc.2019.102840] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu L, Liu Y, Gong L, Zhang M, Wu W. Salvage camrelizumab plus apatinib for relapsed esophageal neuroendocrine carcinoma after esophagectomy: a case report and review of the literature. Cancer Biol Ther 2020;21:983-9. [PMID: 33092443 DOI: 10.1080/15384047.2020.1829265] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Li J, Ma J, Wang H, Niu J, Zhou L. Population-based analysis of small cell carcinoma of the esophagus using the SEER database. J Thorac Dis 2020;12:3529-38. [PMID: 32802432 DOI: 10.21037/jtd-20-1428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zhang Z, Zhang C, Zhang G, Luo Y, Xue L, Zeng Q, Wu P, Wang L, Sun N, He J. Tumor-infiltrating CD8+ T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited-stage small cell esophageal carcinoma. Clin Transl Med 2021;11:e456. [PMID: 34185404 DOI: 10.1002/ctm2.456] [Reference Citation Analysis]
8 Elpek GO. Mixed neuroendocrine–nonneuroendocrine neoplasms of the gastrointestinal system: An update. World J Gastroenterol 2022; 28(8): 794-810 [DOI: 10.3748/wjg.v28.i8.794] [Reference Citation Analysis]
9 Papaefthymiou A, Laskaratos FM, Koffas A, Manolakis A, Gkolfakis P, Coda S, Sodergren M, Suzuki N, Toumpanakis C. State of the Art in Endoscopic Therapy for the Management of Gastroenteropancreatic Neuroendocrine Tumors. Curr Treat Options Oncol 2022. [PMID: 35511346 DOI: 10.1007/s11864-022-00986-w] [Reference Citation Analysis]
10 Ionescu F, Petrescu I, Marin M. Unusual behaviour of an unusual tumour: calcitriol-induced hypercalcaemia in metastatic oesophageal neuroendocrine carcinoma. BMJ Case Rep 2020;13:e235209. [PMID: 32843450 DOI: 10.1136/bcr-2020-235209] [Reference Citation Analysis]
11 Wu IC, Chu YY, Wang YK, Tsai CL, Lin JC, Kuo CH, Shih HY, Chung CS, Hu ML, Sun WC, Wang JP, Wang HP. Clinicopathological features and outcome of esophageal neuroendocrine tumor: A retrospective multicenter survey by the digestive endoscopy society of Taiwan. J Formos Med Assoc 2021;120:508-14. [PMID: 32600867 DOI: 10.1016/j.jfma.2020.06.024] [Reference Citation Analysis]
12 Tustumi F, Marques SSB, Barros EF, Henriques AC, Waisberg J, Dias AR. THE PROGNOSIS OF THE DIFFERENT ESOPHAGEAL NEUROENDOCRINE CARCINOMA SUBTYPES: A POPULATION-BASED STUDY. Arq Gastroenterol 2022;59:53-7. [DOI: 10.1590/s0004-2803.202200001-10] [Reference Citation Analysis]